Researchers discovered the crystal structure of an alternative DNA configuration within the insulin gene, providing insights ...

Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...

such as pembrolizumab (Keytruda), which are already transforming the treatment of cancer. Utilizing computational tools to engineer proteins represents the next frontier in cancer therapeutics. Our ...

Add a description, image, and links to the molecule-driver topic page so that developers can more easily learn about it.

The team, led by Dr. Rafael Bernardi, Associate Professor of Biophysics in the Department of Physics, has developed a novel approach integrating artificial intelligence (AI) with molecular ...

Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug ...

(RTTNews) - IO Biotech (IOBT) announced that the Independent Data Monitoring Committee found the data from the Pivotal Phase 3 Trial of IO102-IO103 in combination with KEYTRUDA (pembrolizumab ...

The new research, however, paints a different picture. The team discovered a gene that produces an RNA molecule—not a protein—controls where dark pigments are made during butterfly metamorphosis.

Merck MRK decided to discontinue two separate phase III studies, KEYNOTE-867 and KEYNOTE-630, evaluating its blockbuster drug Keytruda in patients with certain types of lung cancer and skin cancer ...